Global COVID-19 In-Vitro Diagnostics Market Growth (Status and Outlook) 2023-2029

March 2023 | 91 pages | ID: GA4E3F9073BBEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to this study, the global COVID-19 In-Vitro Diagnostics market size will reach US$ million by 2029.

This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 In-Vitro Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by product type:

• Rapid Diagnostic Test (RDT)
• Enzyme Linked Immunosorbent Assay (ELISA)
• Neutralization Assay

Segmentation by Application:

• Home
• Hospital
• Clinical

This report also splits the market by region:

• United States
• China
• Europe
• Other regions:
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Cellex
• Abbott
• Roche
• BioMedomics
• BD
• Henry Schein
• Safecare Bio-Tech
• Mayo Clinic Laboratories
• Chembio Diagnostics
• Mount Sinai Laboratory
• Ortho Clinical Diagnostics
• Zhejiang Orient Gene Biotech
• Innovita Biological Technology
• Guangzhou Wondfo Biotech
• Guangdong Hecin-Scientific
• Dynamiker Biotechnology (Tianjin)
• ADVAITE

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global COVID-19 In-Vitro Diagnostics Market Size 2024-2029
  2.1.2 COVID-19 In-Vitro Diagnostics Market Size CAGR by Region
2.2 COVID-19 In-Vitro Diagnostics Segment by Type
  2.2.1 Rapid Diagnostic Test (RDT)
  2.2.2 Enzyme Linked Immunosorbent Assay (ELISA)
  2.2.3 Neutralization Assay
2.3 COVID-19 In-Vitro Diagnostics Market Size by Type
  2.3.1 Global COVID-19 In-Vitro Diagnostics Market Size Market Share by Type (2024-2029)
  2.3.2 Global COVID-19 In-Vitro Diagnostics Market Size Growth Rate by Type (2024-2029)
2.4 COVID-19 In-Vitro Diagnostics Segment by Application
  2.4.1 Home
  2.4.2 Hospital
  2.4.3 Clinical
2.5 COVID-19 In-Vitro Diagnostics Market Size by Application
  2.5.1 Global COVID-19 In-Vitro Diagnostics Market Size Market Share by Application (2024-2029)
  2.5.2 Global COVID-19 In-Vitro Diagnostics Market Size Growth Rate by Application (2024-2029)

3 COVID-19 IN-VITRO DIAGNOSTICS KEY PLAYERS

3.1 Date of Key Players Enter into COVID-19 In-Vitro Diagnostics
3.2 Key Players COVID-19 In-Vitro Diagnostics Product Offered
3.3 Key Players COVID-19 In-Vitro Diagnostics Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players COVID-19 In-Vitro Diagnostics Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 COVID-19 IN-VITRO DIAGNOSTICS BY REGIONS

4.1 COVID-19 In-Vitro Diagnostics Market Size by Regions (2024-2029)
4.2 United States COVID-19 In-Vitro Diagnostics Market Size Growth (2024-2029)
4.3 China COVID-19 In-Vitro Diagnostics Market Size Growth (2024-2029)
4.4 Europe COVID-19 In-Vitro Diagnostics Market Size Growth (2024-2029)
4.5 Rest of World COVID-19 In-Vitro Diagnostics Market Size Growth (2024-2029)

5 UNITED STATES

5.1 United States COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2029)
5.2 United States COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2029)

6 EUROPE

6.1 Europe COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2029)
6.2 Europe COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2029)

7 CHINA

7.1 China COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2029)
7.2 China COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2029)

8 REST OF WORLD

8.1 Rest of World COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2029)
8.2 Rest of World COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN COVID-19 IN-VITRO DIAGNOSTICS

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 Cellex
  11.1.1 Cellex Company Details
  11.1.2 Cellex COVID-19 In-Vitro Diagnostics Product Offered
  11.1.3 Cellex COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
  11.1.4 Cellex Main Business Overview
  11.1.5 Cellex News
11.2 Abbott
  11.2.1 Abbott Company Details
  11.2.2 Abbott COVID-19 In-Vitro Diagnostics Product Offered
  11.2.3 Abbott COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
  11.2.4 Abbott Main Business Overview
  11.2.5 Abbott News
11.3 Roche
  11.3.1 Roche Company Details
  11.3.2 Roche COVID-19 In-Vitro Diagnostics Product Offered
  11.3.3 Roche COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
  11.3.4 Roche Main Business Overview
  11.3.5 Roche News
11.4 BioMedomics
  11.4.1 BioMedomics Company Details
  11.4.2 BioMedomics COVID-19 In-Vitro Diagnostics Product Offered
  11.4.3 BioMedomics COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
  11.4.4 BioMedomics Main Business Overview
  11.4.5 BioMedomics News
11.5 BD
  11.5.1 BD Company Details
  11.5.2 BD COVID-19 In-Vitro Diagnostics Product Offered
  11.5.3 BD COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
  11.5.4 BD Main Business Overview
  11.5.5 BD News
11.6 Henry Schein
  11.6.1 Henry Schein Company Details
  11.6.2 Henry Schein COVID-19 In-Vitro Diagnostics Product Offered
  11.6.3 Henry Schein COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
  11.6.4 Henry Schein Main Business Overview
  11.6.5 Henry Schein News
11.7 Safecare Bio-Tech
  11.7.1 Safecare Bio-Tech Company Details
  11.7.2 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Product Offered
  11.7.3 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
  11.7.4 Safecare Bio-Tech Main Business Overview
  11.7.5 Safecare Bio-Tech News
11.8 Mayo Clinic Laboratories
  11.8.1 Mayo Clinic Laboratories Company Details
  11.8.2 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Product Offered
  11.8.3 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
  11.8.4 Mayo Clinic Laboratories Main Business Overview
  11.8.5 Mayo Clinic Laboratories News
11.9 Chembio Diagnostics
  11.9.1 Chembio Diagnostics Company Details
  11.9.2 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Product Offered
  11.9.3 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
  11.9.4 Chembio Diagnostics Main Business Overview
  11.9.5 Chembio Diagnostics News
11.10 Mount Sinai Laboratory
  11.10.1 Mount Sinai Laboratory Company Details
  11.10.2 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Product Offered
  11.10.3 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
  11.10.4 Mount Sinai Laboratory Main Business Overview
  11.10.5 Mount Sinai Laboratory News
11.11 Ortho Clinical Diagnostics
11.12 Zhejiang Orient Gene Biotech
11.13 Innovita Biological Technology
11.14 Guangzhou Wondfo Biotech
11.15 Guangdong Hecin-Scientific
11.16 Dynamiker Biotechnology (Tianjin)
11.17 ADVAITE

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. COVID-19 In-Vitro Diagnostics Market Size CAGR by Region (2024-2029) ($ Millions)
Table 2. Major Players of Rapid Diagnostic Test (RDT)
Table 3. Major Players of Enzyme Linked Immunosorbent Assay (ELISA)
Table 4. Major Players of Neutralization Assay
Table 5. Global COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2029) ($ Millions)
Table 6. Global COVID-19 In-Vitro Diagnostics Market Size Market Share by Type (2024-2029)
Table 7. Global COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2029) ($ Millions)
Table 8. Global COVID-19 In-Vitro Diagnostics Market Size Market Share by Application (2024-2029)
Table 9. Date of Global Key Players Enter into COVID-19 In-Vitro Diagnostics Market
Table 10. Global Key Players COVID-19 In-Vitro Diagnostics Product Offered
Table 11. Key Players COVID-19 In-Vitro Diagnostics Funding/Investment ($ Millions)
Table 12. Funding/Investment by Regions
Table 13. Funding/Investment by End Industry
Table 14. Key Players COVID-19 In-Vitro Diagnostics Valuation & Market Capitalization ($ Millions)
Table 15. Key Players Mergers & Acquisitions, Expansion Plans
Table 16. COVID-19 In-Vitro Diagnostics New Product/Technology Launches
Table 17. COVID-19 In-Vitro Diagnostics Industry Partnerships, Agreements, and Collaborations
Table 18. COVID-19 In-Vitro Diagnostics Industry Mergers and Acquisitions
Table 19. Global COVID-19 In-Vitro Diagnostics Market Size by Regions 2024-2029 ($ Millions)
Table 20. Global COVID-19 In-Vitro Diagnostics Market Size Market Share by Regions 2024-2029
Table 21. United States COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2029) ($ Millions)
Table 22. United States COVID-19 In-Vitro Diagnostics Market Size Market Share by Type (2024-2029)
Table 23. United States COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2029) ($ Millions)
Table 24. United States COVID-19 In-Vitro Diagnostics Market Size Market Share by Application (2024-2029)
Table 25. Europe COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2029) ($ Millions)
Table 26. Europe COVID-19 In-Vitro Diagnostics Market Size Market Share by Type (2024-2029)
Table 27. Europe COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2029) ($ Millions)
Table 28. Europe COVID-19 In-Vitro Diagnostics Market Size Market Share by Application (2024-2029)
Table 29. China COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2029) ($ Millions)
Table 30. China COVID-19 In-Vitro Diagnostics Market Size Market Share by Type (2024-2029)
Table 31. China COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2029) ($ Millions)
Table 32. China COVID-19 In-Vitro Diagnostics Market Size Market Share by Application (2024-2029)
Table 33. Rest of World COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2029) ($ Millions)
Table 34. Rest of World COVID-19 In-Vitro Diagnostics Market Size Market Share by Type (2024-2029)
Table 35. Rest of World COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2029) ($ Millions)
Table 36. Rest of World COVID-19 In-Vitro Diagnostics Market Size Market Share by Application (2024-2029)
Table 37. Key Market Drivers & Growth Opportunities of COVID-19 In-Vitro Diagnostics
Table 38. Key Market Challenges & Risks of COVID-19 In-Vitro Diagnostics
Table 39. Key Industry Trends of COVID-19 In-Vitro Diagnostics
Table 40. Company A Company Details
Table 41. Companies Invested by Company A
Table 42. Company A Key Development and Market Layout
Table 43. Company B Company Details
Table 44. Companies Invested by Company B
Table 45. Company B Key Development and Market Layout
Table 46. Company C Company Details
Table 47. Companies Invested by Company C
Table 48. Company C Key Development and Market Layout
Table 49. Company C Company Details
Table 50. Companies Invested by Company C
Table 51. Company C Key Development and Market Layout
Table 52. Cellex Basic Information, Head Office, Major Market Areas and Its Competitors
Table 53. Cellex COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
Table 54. Abbott Basic Information, Head Office, Major Market Areas and Its Competitors
Table 55. Abbott COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
Table 56. Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table 57. Roche COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
Table 58. BioMedomics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 59. BioMedomics COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
Table 60. BD Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. BD COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
Table 62. Henry Schein Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. Henry Schein COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
Table 64. Safecare Bio-Tech Basic Information, Head Office, Major Market Areas and Its Competitors
Table 65. Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
Table 66. Mayo Clinic Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
Table 67. Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
Table 68. Chembio Diagnostics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 69. Chembio Diagnostics COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
Table 70. Mount Sinai Laboratory Basic Information, Head Office, Major Market Areas and Its Competitors
Table 71. Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
Table 72. Ortho Clinical Diagnostics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 73. Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
Table 74. Zhejiang Orient Gene Biotech Basic Information, Head Office, Major Market Areas and Its Competitors
Table 75. Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
Table 76. Innovita Biological Technology Basic Information, Head Office, Major Market Areas and Its Competitors
Table 77. Innovita Biological Technology COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
Table 78. Guangzhou Wondfo Biotech Basic Information, Head Office, Major Market Areas and Its Competitors
Table 79. Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
Table 80. Guangdong Hecin-Scientific Basic Information, Head Office, Major Market Areas and Its Competitors
Table 81. Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
Table 82. Dynamiker Biotechnology (Tianjin) Basic Information, Head Office, Major Market Areas and Its Competitors
Table 83. Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)
Table 84. ADVAITE Basic Information, Head Office, Major Market Areas and Its Competitors
Table 85. ADVAITE COVID-19 In-Vitro Diagnostics Market Size (2023 VS 2029)

List Of Figures

LIST OF FIGURES

Figure 1. Picture of COVID-19 In-Vitro Diagnostics
Figure 2. COVID-19 In-Vitro Diagnostics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global COVID-19 In-Vitro Diagnostics Market Size Growth Rate 2024-2029 ($ Millions)
Figure 7. COVID-19 In-Vitro Diagnostics Market Size by Region (2023 & 2029) ($ millions)
Figure 8. Global COVID-19 In-Vitro Diagnostics Market Size Market Share by Type (2024-2029)
Figure 9. Global Rapid Diagnostic Test (RDT) Market Size Growth Rate
Figure 10. Global Enzyme Linked Immunosorbent Assay (ELISA) Market Size Growth Rate
Figure 11. Global Neutralization Assay Market Size Growth Rate
Figure 12. COVID-19 In-Vitro Diagnostics in Home
Figure 13. Global COVID-19 In-Vitro Diagnostics Market: Home (2024-2029) ($ Millions)
Figure 14. COVID-19 In-Vitro Diagnostics in Hospital
Figure 15. Global COVID-19 In-Vitro Diagnostics Market: Hospital (2024-2029) ($ Millions)
Figure 16. COVID-19 In-Vitro Diagnostics in Clinical
Figure 17. Global COVID-19 In-Vitro Diagnostics Market: Clinical (2024-2029) ($ Millions)
Figure 18. Global COVID-19 In-Vitro Diagnostics Market Size Market Share by Application (2024-2029)
Figure 19. Global COVID-19 In-Vitro Diagnostics Market Size in Home Growth Rate
Figure 20. Global COVID-19 In-Vitro Diagnostics Market Size in Hospital Growth Rate
Figure 21. Global COVID-19 In-Vitro Diagnostics Market Size in Clinical Growth Rate
Figure 22. Funding/Investment
Figure 23. Global COVID-19 In-Vitro Diagnostics Market Size Market Share by Regions 2024-2029
Figure 24. United States COVID-19 In-Vitro Diagnostics Market Size 2024-2029 ($ Millions)
Figure 25. China COVID-19 In-Vitro Diagnostics Market Size 2024-2029 ($ Millions)
Figure 26. Europe COVID-19 In-Vitro Diagnostics Market Size 2024-2029 ($ Millions)
Figure 27. Rest of World COVID-19 In-Vitro Diagnostics Market Size 2024-2029 ($ Millions)
Figure 28. United States COVID-19 In-Vitro Diagnostics Consumption Market Share by Type in 2029
Figure 29. United States COVID-19 In-Vitro Diagnostics Market Size Market Share by Application in 2029
Figure 30. China COVID-19 In-Vitro Diagnostics Consumption Market Share by Type in 2029
Figure 31. China COVID-19 In-Vitro Diagnostics Market Size Market Share by Application in 2029
Figure 32. Europe COVID-19 In-Vitro Diagnostics Consumption Market Share by Type in 2029
Figure 33. Europe COVID-19 In-Vitro Diagnostics Market Size Market Share by Application in 2029
Figure 34. Rest of World COVID-19 In-Vitro Diagnostics Consumption Market Share by Type in 2029
Figure 35. Rest of World COVID-19 In-Vitro Diagnostics Market Size Market Share by Application in 2029